Could stress play a role in the development of breast cancer?
Researchers from the University of Illinois at Chicagowondered about this. After all, the components of what experts call “psychosocial stress” – including fear, anxietyand isolation – could take a toll on the autonomic nervous system, which helps regulate heart rate, respiration and other important bodily functions.
So they found 989 women who had been diagnosed with breast cancer in the previous three months and asked them a lot of questions to assess their level of stress. It turned out that there was an association between stress and the disease – the women who scored highest for stress were more likely to have a more aggressive form of breast cancer.
More specifically, the researchers found that stressed women were 38% more likely to have cancers that were estrogen receptor-negative. These tumors do not respond to therapies aimed at cutting off estrogen, which means that drugs likeTamoxifen, raloxifene (Evista), Arimidex and others will not help. After taking into account things like the women’s age and the stage of their cancer when it was diagnosed, the women who were more stressed were still 22% more likely to have cancers that were estrogen receptor-negative.
Researchers from the University of Illinois at Chicagowondered about this. After all, the components of what experts call “psychosocial stress” – including fear, anxietyand isolation – could take a toll on the autonomic nervous system, which helps regulate heart rate, respiration and other important bodily functions.
So they found 989 women who had been diagnosed with breast cancer in the previous three months and asked them a lot of questions to assess their level of stress. It turned out that there was an association between stress and the disease – the women who scored highest for stress were more likely to have a more aggressive form of breast cancer.
More specifically, the researchers found that stressed women were 38% more likely to have cancers that were estrogen receptor-negative. These tumors do not respond to therapies aimed at cutting off estrogen, which means that drugs likeTamoxifen, raloxifene (Evista), Arimidex and others will not help. After taking into account things like the women’s age and the stage of their cancer when it was diagnosed, the women who were more stressed were still 22% more likely to have cancers that were estrogen receptor-negative.